CP-3

N/A

Report date: 2023/08/01 09:47:03
NME

Base Information

Drug NameCP-3
Drug Alias NameCP-3
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChild Development Disorders, Pervasive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStalicla Sa
China Registration ClassN/A

Develop Information

Active CompaniesStalicla Sa
Inactive CompaniesN/A
Active IndicationsChild Development Disorders, Pervasive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A